Global Cannabis Gummies Market
Market Size in USD Billion
CAGR :
%
USD
13.30 Billion
USD
108.49 Billion
2021
2029
| 2022 –2029 | |
| USD 13.30 Billion | |
| USD 108.49 Billion | |
|
|
|
|
Global Cannabis Gummies By Concentration (High, Low Concentration), Distribution Channel (Online and Offline), Type (Solid Edible, Topical Edible, Inhalation and Liquid Edible), Preparation (Cannabidiol and Tetrahydrocannabinol), Application (Cancer, Epilepsy, Arthritis, Multiple Sclerosis, Alzheimer, Anorexia and Nausea) – Industry Trends and Forecast to 2029
Market Analysis and Size
The industry's interest in CBD-based products has skyrocketed as a result of the general public's efforts to legalise marijuana for medicinal and recreational purposes. As a result of their non-psychotropic effects, CBD gummies have gained popularity among consumers. The growing range of medicinal applications for CBD gummies, such as neurological disorders, psychiatric disorders, and cancer therapeutics, is a key driver of the CBD gummies market's evolution.
Data Bridge Market Research analyses that the Cannabis gummies market which was valued at USD 13.3 billion in 2021 and is expected to reach the value of USD 108.49 billion by 2029, at a CAGR of 30.00% during the forecast period of 2022-2029.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2019 - 2014) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Concentration (High, Low Concentration), Distribution Channel (Online and Offline), Type (Solid Edible, Topical Edible, Inhalation and Liquid Edible), Preparation (Cannabidiol and Tetrahydrocannabinol), Application (Cancer, Epilepsy, Arthritis, Multiple Sclerosis, Alzheimer, Anorexia and Nausea) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Global, Brazil, Argentina, Rest of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa |
|
Market Players Covered |
Canopy Growth Corporation (Canada), The Cronos Group (Canada), Tilray. (US), Hexo (Canada), CannTrust (Canada), Aurora Cannabis Inc. (Canada), GW Pharmaceuticals plc. (UK), VIVO Cannabis Inc. (Canada), Alkaline88, LLC. (US), NewAge Inc. (US), Cannara. (Canada), Dixie Brands (US), KANNAWAY LLC. (US), The Supreme Cannabis Company, Inc (Canada), CANNABIS Aphria (Canada), CURA CS, LLC. (US), KAZMIRA (US), Curaleaf (US) and CannazALL (US) |
|
Opportunities |
|
Market Definition
CBD gummies are edible candies that contain non-psychoactive cannabidiol oil derived from the marijuana plant. These gummies are widely available in a variety of shapes, flavors, colours, and cannabidiol concentrations. CBD gummies are easily ingestible and aid in relieving chronic pain, reducing anxiety and depression, reducing stress, the treatment of insomnia and other ailments.
Cannabis Gummies Market Dynamics
Drivers
- Rising legalization of cannabis for medicinal and recreational purposes
The increasing legalization of cannabis for a variety of medical and recreational purposes, particularly across borders, is increasing demand for CBD gummies. Furthermore, rising consumer awareness of the numerous benefits of CBD gummies in treating inflammation, relieving pain, improving sleep quality, and stress management is propelling market growth.
- The rising prevalence of neurological and psychiatric disorders among population
The rising prevalence of several respiratory ailments caused by cannabis smoking has shifted consumer preference for CBD-infused edibles, such as CBD gummies. Furthermore, the non-psychotropic features of CBD gummies, which reduce the risk of drug-induced sensations among consumers, are boosting the adoption of CBD gummies due to the increased prevalence of various neurological and mental illnesses. Furthermore, the emergence of gluten-free, vegan, sugar-free, and organic CBD gummies, typically made from non-GMO hemp plants, catalyzes market growth.
Opportunity
One of the major contributors to the growth of the CBD gummies market is the healthcare sector. CBD gummies can help us control our bodies' inflammatory responses. CBD products, such as gummies, are gaining popularity as an alternative to traditional analgesics like ibuprofen, aspirin, and others. CBD has been discovered to have powerful anti-anxiety and anti-depressant properties. Furthermore, it has been shown to increase neurogenesis (brain cell growth) in key areas of the brain associated with anxiety and depression. All of these factors will play a significant role in driving market growth in the coming years.
Restraints
Most CBD products are not FDA-approved because their strengths and purity can vary between brands and even within the same brand, potentially resulting in less-than-desired positive outcomes. As a result, their use is restricted in a number of countries. Furthermore, the availability of substitutes such as CBD dark chocolates, salad dressings, and protein supplements is a significant impediment to effective adoption, limiting growth prospects.
This cannabis gummies market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cannabis gummies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Cannabis Gummies Market
COVID-19, like any other market, had a negative impact on the cannabis market. Consumers were discouraged from visiting brick-and-mortar stores as a result of the lockdown. However, many cannabis companies began to rely heavily on social media and e-commerce platforms to market to consumers during the year. The Alberta government designated cannabis retail shops, producers, manufacturers, distributors, and warehouses as essential services on March 30, 2020. As a result, throughout the COVID-19 pandemic, cannabis businesses and services continued to serve Albertans.
Recent Development
- Canopy Growth, one of the world's largest cannabis companies, announced in June 2021 that it had completed the acquisition of The Supreme Cannabis Company and had acquired 100 percent of Supreme's issued and outstanding common shares.
- STADA Arzneimittel AG, one of Germany's largest pharmaceutical firms, will enter the medical cannabis space in March 2021 with an agreement with Canadian firm MediPharm Labs for the launch of two flower products, with six more to follow
- TCV Sciences, Inc. announced the release of PLUSCBDTM calm and sleep gummies in May 2021, two flavorful gummies that support healthy stress responses and sleep cycles for people returning to their normal routines.
- Pfizer Inc. and GSK merged their respective consumer healthcare businesses in 2019 to form GSK Consumer Healthcare, a global consumer healthcare joint venture.
Global Cannabis Gummies Market Scope
The cannabis gummies market is segmented on the basis of concentration, distribution channel, type, preparation and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Concentration
- High
- Low
Type
- Solid Edible
- Topical Edible
- Inhalation
- Liquid Edible
Preparation
- Cannabidiol
- Tetrahydrocannabinol
Application
- Cancer
- Epilepsy
- Arthritis
- Multiple Sclerosis
- Alzheimer
- Anorexia
- Nausea
Distribution channel
- Online
- Offline
Cannabis Gummies Market Regional Analysis/Insights
The cannabis gummies market is analysed and market size insights and trends are provided by country, source, products, consumer, packaging, and sales channel as referenced above.
The countries covered in the cannabis gummies market report are U.S., Canada, Mexico, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Global, Brazil, Argentina, Rest of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa.
The North American region, which has experienced significant year-on-year growth, is expected to drive the global CBD gummies market. The rising demand for recreational and medicinal marijuana and products for heart health, stamina, and bone health is a major driver of the CBD gummies market's expansion. Additionally, products aimed specifically at children are driving innovation, particularly those addressing immune and gut health, which are expected to gain traction in the coming years. The North American market may also see increased demand for vegan/plant-based products in various fruit flavours, which may contribute to the region's market development.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Cannabis Gummies Market Share Analysis
The cannabis gummies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cannabis gummies market.
Some of the major players operating in the cannabis gummies market are:
- Canopy Growth Corporation (Canada)
- The Cronos Group (Canada)
- Tilray. (US)
- Hexo (Canada)
- CannTrust (Canada)
- Aurora Cannabis Inc. (Canada)
- GW Pharmaceuticals plc. (UK)
- VIVO Cannabis Inc. (Canada)
- Alkaline88, LLC. (US)
- NewAge Inc. (US)
- Cannara. (Canada)
- Dixie Brands (US)
- KANNAWAY LLC. (US)
- The Supreme Cannabis Company, Inc (Canada)
- CANNABIS Aphria (Canada)
- CURA CS, LLC. (US)
- KAZMIRA (US)
- Curaleaf (US)
- CannazALL (US)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL CANNABIS GUMMIES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL CANNABIS GUMMIES MARKETSIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMAPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 DEMAND AND SUPPLY-SIDE VARIABLES
2.2.8 TOP TO BOTTOM ANALYSIS
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL CANNABIS GUMMIES MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 SUPPLY CHAIN ANALYSIS
5.2 FACTORS INFLUENCING PURCHASING DECISION
5.3 INDUTRY TRENDS AND FUTURE PERSPECTIVES
5.4 SHOPPING BEHAVIOUR AND DYNAMICS
5.4.1 RECOMMENDATION FROM FAMILY & FRIENDS
5.4.2 RESEARCH
5.4.3 IMPULSIVE
5.4.4 ADVERTISEMENT
5.4.4.1. TTELEVISION ADVERTISEMENT
5.4.4.2. OONLINE ADVERTISEMENT
5.4.4.3. IIN-STORE ADVERTISEMENT
5.4.4.4. OOUTDOOR ADVERTISEMENT
5.5 PRIVATE LABEL VS BRAND ANALYSIS
5.6 PROMOTIONAL ACTIVITIES
5.7 CONSUMER DISPOSABLE INCOME DYNAMICS/SPEND DYNAMICS
5.8 NEW PRODUCT LAUNCH STRATEGY
5.8.1 NUMBER OF NEW PRODUCT LAUNCH
5.8.1.1. LINE EXTENSTION
5.8.1.2. NEW PACKAGING
5.8.1.3. RE-LAUNCHED
5.8.1.4. NEW FORMULATION
5.9 CONSUMER LEVEL TRENDS
5.1 MEETING CONSUMER REQUIREMENT
6 REGULATORY FRAMEWORK AND GOVERNMENT INITIATIVES
7 IMPACT OF ECONOMIC SLOW DOWN ON MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON SUPPLY CHAIN
7.3 IMPACT ON SHIPMENT
7.4 IMPACT ON COMPANY’S STRATEGIC DECISIONS
8 PRICING ANALYSIS
9 PRODUCTION CAPACITY OF KEY MANUFACTURERES
10 BRAND OUTLOOK
10.1 COMPARATIVE BRAND ANALYSIS
10.2 PRODUCT VS BRAND OVERVIEW
11 GLOBAL CANNABIS GUMMIES MARKET, BY GUMMY FORM, 2022-2031 (USD MILLION)
11.1 OVERVIEW
11.2 GUMMY BEARS
11.3 GUMMY RINGS
11.4 GUMMY WORMS
11.5 OTHERS
12 GLOBAL CANNABIS GUMMIES MARKET, BY CBD TYPE, 2022-2031 (USD MILLION)
12.1 OVERVIEW
12.2 FULL-SPECTRUM CBD
12.3 CBD ISOLATE
12.4 BROAD-SPECTRUM CBD
13 GLOBAL CANNABIS GUMMIES MARKET, BY CONCENTRATION, 2022-2031 (USD MILLION)
13.1 OVERVIEW
13.2 HIGH CONCENTRATION
13.2.1 HIGH CONCENTRATION, BY CBD CONTENT PER GUMMY
13.2.1.1. 101-250MG
13.2.1.2. 250-500- MG
13.2.1.3. >500 MG
13.2.1.4. OTHERSS
13.3 LOW CONCENTRATION
13.3.1 LOW CONCENTRATION, BY CBD CONTENT PER GUMMY
13.3.1.1. 10 MG
13.3.1.2. 20 MG
13.3.1.3. 25 MG
13.3.1.4. 50 MG
13.3.1.5. 51 TO 100 MG
14 GLOBAL CANNABIS GUMMIES MARKET, BY FLAVOR, 2022-2031 (USD MILLION)
14.1 OVERVIEW
14.2 TANGERINE
14.3 STRAWBERRY
14.4 BLUEBERRY
14.5 CHERRY
14.6 RASPBERRY
14.7 BLACKBERRY
14.8 BANANA
14.9 CRANBERRY
14.1 WATERMELON
14.11 ORANGE
14.12 PINEAPPLE
14.13 APPLE
14.14 LIME
14.15 BLACKCURRENT
14.16 MANGO
14.17 SOUR
14.18 OTHERS
15 GLOBAL CANNABIS GUMMIES MARKET, BY NATURE, 2022-2031 (USD MILLION)
15.1 OVERVIEW
15.2 ORGANIC
15.3 CONVENTIONAL
16 GLOBAL CANNABIS GUMMIES MARKET, BY USAGE TYPE, 2022-2031 (USD MILLION)
16.1 OVERVIEW
16.2 RECREATIONAL
16.3 MEDICINAL
16.3.1 MEDICINAL, BY TYPE
16.3.1.1. CANCER
16.3.1.2. EPILEPSY
16.3.1.3. ARTHRITIS
16.3.1.4. MULTIPLE SCLEROSIS
16.3.1.5. ALZHEIMER
16.3.1.6. ANOREXIA
16.3.1.7. NAUSEA
16.3.1.8. DIABETES
16.3.1.9. DEPRESSION
16.3.1.10. ANXIETY
16.3.1.11. OTHERS
17 GLOBAL CANNABIS GUMMIES MARKET, BY PACKAGING TYPE, 2022-2031 (USD MILLION)
17.1 OVERVIEW
17.2 JAR / BOTTLES
17.2.1 GLASS JAR
17.2.2 PLASTIC JARS
17.3 POUCHES
17.4 OTHERS
18 GLOBAL CANNABIS GUMMIES MARKET, BY PACKAGING SIZE, 2022-2031 (USD MILLION)
18.1 OVERVIEW
18.2 LESS THAN 100 GRAMS
18.3 101-200 GRAMS
18.4 201-300 GRAMS
18.5 301-400 GRAMS
18.6 401-500 GRAMS
18.7 MORE THAN 500 GRAMS
19 GLOBAL CANNABIS GUMMIES MARKET, BY END USER, 2022-2031 (USD MILLION)
19.1 OVERVIEW
19.2 ADULTS
19.2.1 MEN
19.2.2 WOMEN
19.3 KIDS
20 GLOBAL CANNABIS GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
20.1 OVERVIEW
20.2 STORE BASED RETAILERS
20.2.1 HYPERMARKETS / SUPERMARKETS
20.2.2 GROCERY STORES
20.2.3 CONVENIENCE STORES
20.2.4 SPECIALTY STORES
20.2.5 OTHERS
20.3 NON-STORE RETAILERS
20.3.1 COMPANY OWNED WEBSITES
20.3.2 E-COMMERCE WEBSITES
21 GLOBAL CANNABIS GUMMIES MARKET, COMPANY LANDSCAPE
21.1 COMPANY SHARE ANALYSIS: GLOBAL
21.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
21.3 COMPANY SHARE ANALYSIS: EUROPE
21.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
21.5 MERGERS & ACQUISITIONS
21.6 NEW PRODUCT DEVELOPMENT & APPROVALS
21.7 EXPANSIONS & PARTNERSHIP
21.8 REGULATORY CHANGES
22 GLOBAL CANNABIS GUMMIES MARKET, BY GEOGRAPHY, 2022-2031 (USD MILLION)
22.1 OVERVIEW (ALL SEGMENTATION PROVIDED ABOVE IS REPRESNTED IN THIS CHAPTER BY COUNTRY)
22.2 NORTH AMERICA
22.2.1 U.S.
22.2.2 CANADA
22.2.3 MEXICO
22.3 EUROPE
22.3.1 GERMANY
22.3.2 U.K.
22.3.3 ITALY
22.3.4 FRANCE
22.3.5 SPAIN
22.3.6 SWITZERLAND
22.3.7 NETHERLANDS
22.3.8 BELGIUM
22.3.9 RUSSIA
22.3.10 DENMARK
22.3.11 SWEDEN
22.3.12 POLAND
22.3.13 TURKEY
22.3.14 NORWAY
22.3.15 FINLAND
22.3.16 REST OF EUROPE
22.4 ASIA-PACIFIC
22.4.1 JAPAN
22.4.2 CHINA
22.4.3 SOUTH KOREA
22.4.4 INDIA
22.4.5 AUSTRALIA
22.4.6 SINGAPORE
22.4.7 THAILAND
22.4.8 INDONESIA
22.4.9 MALAYSIA
22.4.10 PHILIPPINES
22.4.11 NEW ZEALAND
22.4.12 VIETNAM
22.4.13 TAIWAN
22.4.14 REST OF ASIA-PACIFIC
22.5 SOUTH AMERICA
22.5.1 BRAZIL
22.5.2 ARGENTINA
22.5.3 REST OF SOUTH AMERICA
22.6 MIDDLE EAST AND AFRICA
22.6.1 SOUTH AFRICA
22.6.2 UAE
22.6.3 SAUDI ARABIA
22.6.4 OMAN
22.6.5 QATAR
22.6.6 KUWAIT
22.6.7 ISRAEL
22.6.8 BAHRAIN
22.6.9 EGYPT
22.6.10 REST OF MIDDLE EAST AND AFRICA
23 GLOBAL CANNABIS GUMMIES MARKET, SWOT & DBMR ANALYSIS
24 GLOBAL CANNABIS GUMMIES MARKET, COMPANY PROFILE
24.1 CV SCIENCES, INC.
24.1.1 COMPANY OVERVIEW
24.1.2 GEOGRAPHICAL PRESENCE
24.1.3 PRODUCTION CAPACITY OVERVIEW
24.1.4 PRODUCT PORTFOLIO
24.1.5 RECENT DEVELOPMENTS
24.2 DIXIE BRANDS, INC.
24.2.1 COMPANY OVERVIEW
24.2.2 GEOGRAPHICAL PRESENCE
24.2.3 PRODUCTION CAPACITY OVERVIEW
24.2.4 PRODUCT PORTFOLIO
24.2.5 RECENT DEVELOPMENTS
24.3 RELIVA WELLNESS (AURORA)
24.3.1 COMPANY OVERVIEW
24.3.2 GEOGRAPHICAL PRESENCE
24.3.3 PRODUCTION CAPACITY OVERVIEW
24.3.4 PRODUCT PORTFOLIO
24.3.5 RECENT DEVELOPMENTS
24.4 SUNDAY SCARIES
24.4.1 COMPANY OVERVIEW
24.4.2 GEOGRAPHICAL PRESENCE
24.4.3 PRODUCTION CAPACITY OVERVIEW
24.4.4 PRODUCT PORTFOLIO
24.4.5 RECENT DEVELOPMENTS
24.5 GREEN ROADS
24.5.1 COMPANY OVERVIEW
24.5.2 GEOGRAPHICAL PRESENCE
24.5.3 PRODUCTION CAPACITY OVERVIEW
24.5.4 PRODUCT PORTFOLIO
24.5.5 RECENT DEVELOPMENTS
24.6 MEDIX CBD
24.6.1 COMPANY OVERVIEW
24.6.2 GEOGRAPHICAL PRESENCE
24.6.3 PRODUCTION CAPACITY OVERVIEW
24.6.4 PRODUCT PORTFOLIO
24.6.5 RECENT DEVELOPMENTS
24.7 HEMP BOMBS
24.7.1 COMPANY OVERVIEW
24.7.2 GEOGRAPHICAL PRESENCE
24.7.3 PRODUCTION CAPACITY OVERVIEW
24.7.4 PRODUCT PORTFOLIO
24.7.5 RECENT DEVELOPMENTS
24.8 PUREKANA
24.8.1 COMPANY OVERVIEW
24.8.2 GEOGRAPHICAL PRESENCE
24.8.3 PRODUCTION CAPACITY OVERVIEW
24.8.4 PRODUCT PORTFOLIO
24.8.5 RECENT DEVELOPMENTS
24.9 DIAMOND WELLNESS HOLDINGS, INC.
24.9.1 COMPANY OVERVIEW
24.9.2 GEOGRAPHICAL PRESENCE
24.9.3 PRODUCTION CAPACITY OVERVIEW
24.9.4 PRODUCT PORTFOLIO
24.9.5 RECENT DEVELOPMENTS
24.1 PREMIUM JANE
24.10.1 COMPANY OVERVIEW
24.10.2 GEOGRAPHICAL PRESENCE
24.10.3 PRODUCTION CAPACITY OVERVIEW
24.10.4 PRODUCT PORTFOLIO
24.10.5 RECENT DEVELOPMENTS
24.11 CHARLOTTE'S WEB HOLDINGS INC
24.11.1 COMPANY OVERVIEW
24.11.2 GEOGRAPHICAL PRESENCE
24.11.3 PRODUCTION CAPACITY OVERVIEW
24.11.4 PRODUCT PORTFOLIO
24.11.5 RECENT DEVELOPMENTS
24.12 VERMA FARMS (ACQUIRED BY FE INTERNATIONAL)
24.12.1 COMPANY OVERVIEW
24.12.2 GEOGRAPHICAL PRESENCE
24.12.3 PRODUCTION CAPACITY OVERVIEW
24.12.4 PRODUCT PORTFOLIO
24.12.5 RECENT DEVELOPMENTS
24.13 HEMPZILLA CBD
24.13.1 COMPANY OVERVIEW
24.13.2 GEOGRAPHICAL PRESENCE
24.13.3 PRODUCTION CAPACITY OVERVIEW
24.13.4 PRODUCT PORTFOLIO
24.13.5 RECENT DEVELOPMENTS
24.14 ZENBEARS CBD
24.14.1 COMPANY OVERVIEW
24.14.2 GEOGRAPHICAL PRESENCE
24.14.3 PRODUCTION CAPACITY OVERVIEW
24.14.4 PRODUCT PORTFOLIO
24.14.5 RECENT DEVELOPMENTS
24.15 ENDOCA
24.15.1 COMPANY OVERVIEW
24.15.2 GEOGRAPHICAL PRESENCE
24.15.3 PRODUCTION CAPACITY OVERVIEW
24.15.4 PRODUCT PORTFOLIO
24.15.5 RECENT DEVELOPMENTS
24.16 CIBDOL
24.16.1 COMPANY OVERVIEW
24.16.2 GEOGRAPHICAL PRESENCE
24.16.3 PRODUCTION CAPACITY OVERVIEW
24.16.4 PRODUCT PORTFOLIO
24.16.5 RECENT DEVELOPMENTS
24.17 FLORA GROWTH CORP.
24.17.1 COMPANY OVERVIEW
24.17.2 GEOGRAPHICAL PRESENCE
24.17.3 PRODUCTION CAPACITY OVERVIEW
24.17.4 PRODUCT PORTFOLIO
24.17.5 RECENT DEVELOPMENTS
24.18 HEMPURA
24.18.1 COMPANY OVERVIEW
24.18.2 GEOGRAPHICAL PRESENCE
24.18.3 PRODUCTION CAPACITY OVERVIEW
24.18.4 PRODUCT PORTFOLIO
24.18.5 RECENT DEVELOPMENTS
24.19 CANNARAY
24.19.1 COMPANY OVERVIEW
24.19.2 GEOGRAPHICAL PRESENCE
24.19.3 PRODUCTION CAPACITY OVERVIEW
24.19.4 PRODUCT PORTFOLIO
24.19.5 RECENT DEVELOPMENTS
24.2 TAURIGA SCIENCES INC
24.20.1 COMPANY OVERVIEW
24.20.2 GEOGRAPHICAL PRESENCE
24.20.3 PRODUCTION CAPACITY OVERVIEW
24.20.4 PRODUCT PORTFOLIO
24.20.5 RECENT DEVELOPMENTS
25 RELATED REPORTS
26 CONCLUSION
27 QUESTIONNAIRE
28 ABOUT DATA BRIDGE MARKET RESEARCH
Global Cannabis Gummies Market, Supply Chain Analysis and Ecosystem Framework
To support market growth and help clients navigate the impact of geopolitical shifts, DBMR has integrated in-depth supply chain analysis into its Global Cannabis Gummies Market research reports. This addition empowers clients to respond effectively to global changes affecting their industries. The supply chain analysis section includes detailed insights such as Global Cannabis Gummies Market consumption and production by country, price trend analysis, the impact of tariffs and geopolitical developments, and import and export trends by country and HSN code. It also highlights major suppliers with data on production capacity and company profiles, as well as key importers and exporters. In addition to research, DBMR offers specialized supply chain consulting services backed by over a decade of experience, providing solutions like supplier discovery, supplier risk assessment, price trend analysis, impact evaluation of inflation and trade route changes, and comprehensive market trend analysis.
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

